Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMGP.L Regulatory News (MGP)

  • There is currently no data for MGP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

8 Jul 2020 07:00

RNS Number : 3154S
Medica Group PLC
08 July 2020
 

8 July 2020

 

Medica Group Plc

 

Trading Update

 

Medica Group Plc (LSE: MGP, "Medica" or the "Company"), the UK market leader in the provision of teleradiology services, announces a trading update for the six months ended 30 June 2020.

 

Medica expects revenue for H1 2020 to be £17.0 million, compared to £22.0 million in H1 2019, due to the impact of the COVID-19 pandemic on radiology reporting activity, as previously announced. Medica's cash position remains robust and, despite the decline in revenues, there has been limited impact on the Company's cash generation, with a cash balance of £20.0 million at 30 June 2020 compared to £16.5 million at 31 December 2019.

 

Further to the announcement on 20 May 2020, reporting activity has continued to improve towards levels experienced before the pandemic and the Company returned to profitability in June 2020. To note, Medica has not required any government funding to support its business and the Company has not furloughed any staff.

 

For NightHawk, the Company's out-of-hours service, reporting activity has returned to around 95% of the level experienced prior to the COVID-19 pandemic. The Company expects to maintain this level of activity following the ease of restrictions imposed by the UK government in an attempt to curb the spread of the virus, notwithstanding a return to national or regional lockdowns resulting from subsequent peaks of infection.

 

The Company's routine (elective) reporting has started to increase steadily and is now around 10% of the level experienced prior to the COVID-19 pandemic. Medica expects its routine reporting volumes to continue to increase in the coming months, as NHS hospitals work to process the substantial backlog of elective procedures and government restrictions are eased.

 

Despite the reduction in reporting activity during the period, capacity has strengthened and recruitment has been strong as radiologists realise the benefits of Medica's secure and reliable home-reporting capabilities. In addition, the pandemic has had a limited impact on the Company's ability to drive forward projects in support of the new strategy, which was announced in March 2020. Medica has also taken advantage of the reduction in workload to initiate an operational excellence programme and to accelerate training and implementation of new clinical protocols to improve the quality of its services.

 

Further to the announcement on 30 March 2020, Richard Jones will be joining Medica as Chief Financial Officer on 3 August 2020.

 

Dr. Stuart Quin, Chief Executive Officer of Medica, commented:

"Whilst demand for our services was significantly impacted during the period, particularly our routine service due to the suspension of elective procedures, we are encouraged to see a continuing improvement in activity. This is particularly evident for our Nighthawk service, with activity now similar to pre-COVID-19 levels. We continue to work closely with our clients to provide timely reporting of imaging for elective procedures as they actively manage waiting lists that have built up over the past months.

 

"I want to thank all involved at Medica who have ensured the high level of service we offer the NHS has been sustained during this challenging time. I recognise the professionalism and commitment shown by our reporters working in the front line and our team working hard to maintain our services from their homes. As a result, Medica has been able to quickly adapt and respond to client's needs, strengthening its position as a leader in the provision of teleradiology services."

 

Medica plans to provide an update on guidance for the full year and publish its financial results for the six months ended 30 June 2020 on 14 September 2020.

 

For further information, please contact:  

 

Medica Group Plc:

Roy Davis, Chairman

Stuart Quin, Chief Executive Officer

 

+44 (0)33 33 111 222

 

Investec Bank Plc

Sara Hale

Daniel Adams

 

+44 (0)20 7597 5970

FTI Consulting

Victoria Foster Mitchell

Robert Winder

 

+44 (0)20 3727 1000

 

About MEDICA

 

MEDICA is the UK market leader in the provision of teleradiology services, providing outsourced interpretation and reporting on MRI (magnetic resonance imaging), CT (computerised tomography) and plain film (x-ray) images. The Company currently offers three primary services to hospital radiology departments: NightHawk, an out-of-hours service, routine cross-sectional reporting on MRI and CT scans, and routine plain film reporting on x-ray images.

 

MEDICA has developed a bespoke secure IT platform that provides market-leading linkage between a hospital's Radiology Information System (RIS) and Consultant Radiologists who contract with MEDICA. Direct RIS access ensures that the full wider patient information is available and reviewed with every report.

 

The Company contracts with the largest pool of consultant radiologists outside of the NHS and has been trusted to provide more than 1.3 million examinations annually across its customer base of more than 100 NHS Trusts and various private hospital groups and diagnostic imaging companies. For more information please visit www.medicagroup.co.uk 

 

About Teleradiology

Teleradiology is the electronic transmission of radiological patient images, including plain film (x-rays), CT scans and MRI scans, from one location to another for the purposes of diagnostic interpretation and reporting.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTRRMRTMTBMBRM
Date   Source Headline
28th May 20213:27 pmRNSDirector/PDMR Shareholding
28th May 20212:43 pmRNSDirector/PDMR Shareholding
25th May 20217:00 amRNSPosting of Annual Report and Notice of AGM
11th May 20217:10 amRNSNon-Executive Director Change
11th May 20217:10 amRNSResults for the year ended 31 December 2020
20th Apr 20219:30 amRNSHolding(s) in Company
16th Apr 20219:47 amRNSHolding(s) in Company
29th Mar 202110:48 amRNSHolding(s) in Company
25th Mar 20218:05 amRNSCompletion of Acquisition & Director/PDMR Dealings
23rd Mar 20219:31 amRNSCorrection: Results of Fundraise and TVR
23rd Mar 20217:00 amRNSResults of Fundraise and Total Voting Rights
23rd Mar 20217:00 amRNSRe-release: Proposed acquisition of US-based RadMD
22nd Mar 20215:07 pmRNSProposed Fundraise to raise approximately £16m
22nd Mar 20215:07 pmRNSProposed acquisition of US-based RadMD
19th Mar 20217:00 amRNSMicrosoft Research’s Dr Junaid Bajwa joins as NED
22nd Feb 20217:00 amRNSMedica and Integral Diagnostics establish JV, MedX
11th Feb 202110:09 amRNSHolding(s) in Company
29th Jan 20219:02 amRNSHolding(s) in Company
26th Jan 20217:00 amRNSAppointment of Liberum as Joint Corporate Broker
21st Jan 20217:00 amRNSTrading Update
18th Jan 20217:00 amRNSDr. Robert Lavis appointed Group Medical Director
4th Dec 202011:57 amRNSDirector/PDMR Shareholding
2nd Dec 20209:31 amRNSDirector/PDMR Shareholding
1st Dec 20209:34 amRNSHolding(s) in Company
18th Nov 20204:41 pmRNSSecond Price Monitoring Extn
18th Nov 20204:36 pmRNSPrice Monitoring Extension
12th Nov 20207:00 amRNSDirector/PDMR Shareholding
11th Nov 202012:41 pmRNSHolding(s) in Company
10th Nov 20201:56 pmRNSHolding(s) in Company
6th Nov 20202:26 pmRNSHolding(s) in Company
5th Nov 20207:00 amRNSDirector/PDMR Shareholding
4th Nov 20207:00 amRNSMedica acquires Global Diagnostics Ireland
27th Oct 20209:20 amRNSHolding(s) in Company
22nd Oct 20209:41 amRNSHolding(s) in Company
16th Oct 202011:26 amRNSHolding(s) in Company
7th Oct 202012:34 pmRNSHolding(s) in Company
16th Sep 20201:07 pmRNSDeclaration of Dividend
14th Sep 20207:00 amRNSInterim results demonstrate resilient performance
9th Sep 202010:36 amRNSHolding(s) in Company
25th Aug 20204:41 pmRNSSecond Price Monitoring Extn
25th Aug 20204:36 pmRNSPrice Monitoring Extension
14th Aug 20209:56 amRNSHolding(s) in Company
21st Jul 202010:49 amRNSHolding(s) in Company
8th Jul 20207:00 amRNSTrading Update
11th Jun 20203:22 pmRNSDirector/PDMR Shareholding
1st Jun 20204:54 pmRNSIssue of Equity
28th May 202010:14 amRNSHolding(s) in Company
21st May 202012:55 pmRNSHolding(s) in Company
20th May 20204:25 pmRNSResult of AGM
20th May 20207:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.